In skin cancer, which included basal cell carcinoma, cutaneous squamous cell carcinoma, melanoma (including acral, metastatic, and cutaneous subtypes), and desmoplastic melanoma, PAK1 had the highest frequency of alterations (4%), all of which were amplifications (Figure 3e). This evidence concerns the gene PAK1 and skin neoplasm.